Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants- A Randomized Pilot Study

NCT00750581 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT00750581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00750581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants- A Randomized Pilot Study
Lead sponsor
University of Calgary
Phase
Phase 2/3
Overall status
Terminated
Start date
August 31, 2008
Completion date
January 31, 2013
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus